EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 14 December 2023

Speed is everything for patients: together we can bring medicines faster

BY TERESA GRAHAM, CEO, ROCHE PHARMACEUTICALS, AND CHAIR EFPIA’S PATIENT ACCESS COMMITTEE

Improving access to medicines requires solutions that are developed in partnership with everyone who has a stake in their delivery. With the right ambition and desire for collaboration, we can act now.

The crucial first step is for governments and policymakers to treat spending on health care and innovation as an investment in economic growth and societal advancement. Improving health care and expanding access to innovation are vital for reducing pressure on health care systems, maintaining a healthy and productive society, and driving future economic growth.

An Investment We Can't Ignore: Reflections on the Changing EU Pharmaceutical Landscape
12 December 2023

As Europe revises substantially its pharmaceutical legislative framework for the first time in 20 years, it remains... Read more

Let the stars align: Cancer Policy in the next European Parliament term
11 December 2023

Where should Europe focus 2024 onwards? Read more

European Health Summit - Watch recordings of EFPIA's sessions

Lars Fruergaard Jørgensen, CEO of Novo Nordisk and EFPIA President, and Nathalie Moll, EFPIA Director General, discussed how we can put Europe at the forefront of medical innovation.

Watch the sessions' recordings.

Events

IHI Call Days - calls 6 & 7
25 January 2024 (Virtual event)

The IHI Call Days are your one-stop-shop to get detailed information on our calls for proposals and network with potential... Read more

ACCELERATE 2024 Paediatric Oncology Conference
08 February 2024 (Brussels and virtually)

Join us to advance paediatric oncology drug development. Read more

What we are reading

Faster and better quality information for pregnant women regarding medications
On 11 December 2023 (IHI)

Something as simple as standardisation of data and data collection saves lives.

A patient driven definition of Unmet Medical Need in migraine
On 05 December 2023 (The Parliament Magazine)

Elena Ruiz de la Torre, Executive Director of the European Migraine Headache Alliance (EMHA) spoke to Ingrid Mcgowan,... Read more

Rare disease burden of care and the economic impact on citizens in Germany, France and Italy...
On 30 October 2023 (Chiesi)

Chiesi Global Rare Diseases, with support from IQVIA, set out to quantify the societal impact relative to the significant... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu